| Filed On | Filing |
|---|---|
| 02 Feb 2024 |
8-K/A: Financial Statements and Exhibits
We have acted as counsel to Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), in connection with (i) the preparation and filing of the Registration Statement on Form S-3 (Registration No. 333-272314) filed wi... |
| 24 Apr 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This Separation and General Release Agreement (the “Agreement”) is between Craig Millian (“Millian”) and Corbus Pharmaceuticals Holdings, Inc. (“Company”), and memorializes the separation of Millian’s employment, including the severance ... |
| 15 Feb 2023 |
8-K/A: Material Modification to Rights of Security Holders
To the extent required by Item 3.03 of Form 8-K, the information regarding the Reverse Stock Split contained in Item 5.03 of the Original Form 8-K is incorporated by reference herein. |
| 22 Sep 2021 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 04 Dec 2020 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 21 Apr 2020 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
